Smith & Nephew plc
SNN • Medical - Devices
$29.32
— 0.00 (0.00%)
Current price
EarningsLatest report: Dec 31, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$12.80B
Growth
6.0%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 10.1%Positive free cash flow · 1.97Consistent free cash flow · 5/5Manageable debt level · 0.63Healthy liquidity · 2.57
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 2, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$29.32
Change0.00%
Shares Out436.47M
Market Cap$12.80B
Enterprise Value$15.42B
52W Range29.08 - 38.79
Beta0.67
P/E12.32
P/S1.07
P/B2.42
P/FCF8.77
EV/Sales1.29
Price$29.32
Change0.00%
Shares Out436.47M
Market Cap$12.80B
Enterprise Value$15.42B
52W Range29.08 - 38.79
Beta0.67
P/E12.32
P/S1.07
P/B2.42
P/FCF8.77
EV/Sales1.29
EV/EBITDA5.47
EV/FCF10.56
Earnings Yield8.11%
FCF Yield11.41%
Dividend Yield5.14%
Gross Margin68.01%
Oper. Margin16.27%
Profit Margin10.14%
Debt/Eq0.63
Current Ratio2.57
Quick Ratio1.25
Revenue 5Y5.99%
Target$31.91
Target Upside8.83%
Target Median$31.85
Target Range30.00 - 33.88
Volume1.38M
Avg Volume1.16M
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
80
out of 100
Business Quality
Margins, moat, returns
75/100
Financial Strength
Debt, cash, stability
82/100
Growth Potential
Revenue and expansion
81/100
Price Attractiveness
Cheap or expensive today
76/100
Why this score▼
Stable or improving margins · 10.1%Positive free cash flow · 1.97Consistent free cash flow · 5/5Manageable debt level · 0.63Healthy liquidity · 2.57
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 23 analyst votes · 2026-10-20
59/100
Neutral
Bullish
6
Hold
15
Bearish
2
Price Target
2026-06-25
Low
$30.00
Mean
$30.93
Median
$30.93
High
$31.85
🧾
No insider activity
No recent insider transactions available.